CDK9 and neoplasm: A related effect has been observed in tumor cells in which the activation of BRG1, due to the inhibition of CDK9 that phosphorylates and inactivates BRG1, prevents its recruitment to heterochromatin and leads to a broad opening of chromatin and the reactivation of transcription of repressed genes62.